Lunai Bioworks (LNAI) Interest & Investment Income (2014 - 2024)
Lunai Bioworks (LNAI) recorded quarterly Interest & Investment Income of $126598.0 in Q3 2024, up 878.01% quarter-over-quarter from -$16272.0 in Q1 2024, and up 1411.62% on a YoY basis from $8375.0 in Q4 2023.
Lunai Bioworks (LNAI) Interest & Investment Income (2014 - 2024) Analysis & Trends
Lunai Bioworks' Interest & Investment Income history runs 10 years deep, the most recent figure standing at $126598.0 for Q3 2024.
- In Q3 2024, Interest & Investment Income rose 1411.62% year-over-year to $126598.0; the TTM figure through Sep 2024 stood at -$23870.0 (up 80.99% YoY), while the FY2022 annual figure was $122041.0, up 826.03% from the prior year.
- Interest & Investment Income was $126598.0 for Q3 2024 at Lunai Bioworks, up from -$16272.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $126598.0 in Q3 2024 to a low of -$142571.0 in Q1 2023.
- Historically, Interest & Investment Income has averaged $8582.9 across 5 years, with a median of $5297.5 in 2020.
- The sharpest annual moves came in 2022 and 2023: Interest & Investment Income jumped 2168.95% in 2022, then slumped 2055.44% in 2023.
- A 5-year view of Interest & Investment Income shows it stood at $3066.0 in 2020, then jumped by 176.81% to $8487.0 in 2021, then sank by 64.53% to $3010.0 in 2022, then soared by 178.24% to $8375.0 in 2023, then jumped by 1411.62% to $126598.0 in 2024.
- The last three Interest & Investment Income figures came in at $126598.0 (Q3 2024), -$16272.0 (Q1 2024), and $8375.0 (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 126,598.00 |
| Mar 31, 2024 | -16,272.00 |
| Sep 30, 2023 | 8,375.00 |
| Mar 31, 2023 | -142,571.00 |
| Dec 31, 2022 | 3,010.00 |
| Sep 30, 2022 | 5,623.00 |
| Jun 30, 2022 | 99,153.00 |
| Mar 31, 2022 | 7,291.00 |
| Dec 31, 2021 | 8,487.00 |
| Sep 30, 2021 | 7,110.00 |
| Jun 30, 2021 | 4,370.00 |
| Mar 31, 2021 | 1,437.00 |
| Dec 31, 2020 | 3,066.00 |
| Sep 30, 2020 | 4,306.00 |
| Jun 30, 2020 | 4,972.00 |
| Mar 31, 2020 | 12,371.00 |
| Dec 31, 2019 | 18,400.00 |
| Sep 30, 2019 | 14,553.00 |
| Jun 30, 2019 | 956.00 |
| Mar 31, 2019 | 8,724.00 |